Stabilized X-ray Contrast Agent Preparation via pH-Adjusted Thermal Processing

The patent applies preliminary pH adjustment to 2.0-4.5 before heating to protect the contrast agent from degradation. This preliminary chemical modification creates a protective environment that allows subsequent high-temperature heating (60-200°C) to achieve complete dissolution without causing the harmful degradation and precipitation that would normally occur under such thermal stress.

The patent fundamentally changes the chemical parameter (pH) of the carrier solution to a specific range (2.0-4.5) before applying thermal energy. This parameter change enables the system to tolerate much higher temperatures (60-200°C) than conventional methods, achieving complete dissolution while avoiding degradation by operating in a different chemical regime that stabilizes the contrast agent under extreme thermal conditions.

The patent performs preliminary pH adjustment to 2.0-4.5 before applying high heat load, which prevents the harmful side effects of free iodide generation and excessive pH reduction. This preliminary chemical conditioning allows the system to withstand temperatures of 60-200°C necessary for dissolving high-temperature compounds like Compound I, while maintaining safety parameters through the protective acidic environment that suppresses degradation reactions.

The patent changes the chemical parameter (pH) to a specific range (2.0-4.5) that fundamentally alters the thermal stability characteristics of the contrast agent. This parameter change enables the use of higher temperatures (60-200°C) to achieve complete dissolution of compounds with inherently high dissolution temperatures, while simultaneously controlling the generation of harmful free iodide and preventing excessive pH drops that would compromise patient safety.